These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11252112)

  • 21. Quality of care of Medicare beneficiaries with acute myocardial infarction: who is included in quality improvement measurement?
    Rathore SS; Wang Y; Radford MJ; Ordin DL; Krumholz HM
    J Am Geriatr Soc; 2003 Apr; 51(4):466-75. PubMed ID: 12657065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of effectiveness of angiotensin-converting enzyme inhibitors after acute myocardial infarction in diabetic versus nondiabetic patients.
    Gottlieb S; Leor J; Shotan A; Harpaz D; Boyko V; Rott D; Mandelzweig L; Behar S;
    Am J Cardiol; 2003 Nov; 92(9):1020-5. PubMed ID: 14583350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction.
    Hansen ML; Gislason GH; Køber L; Schramm TK; Folke F; Buch P; Abildstrom SZ; Madsen M; Rasmussen S; Torp-Pedersen C
    Br J Clin Pharmacol; 2008 Feb; 65(2):217-23. PubMed ID: 17711535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of acute myocardial infarction in the experience of a community hospital. A prospective study].
    Tincani E; Mazzoli V; Bondi M
    Minerva Cardioangiol; 1997; 45(7-8):335-47. PubMed ID: 9463169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.
    Harjai KJ; Solis S; Prasad A; Loupe J
    Int J Cardiol; 2003 Apr; 88(2-3):207-14. PubMed ID: 12714200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
    Teo KK; Yusuf S; Pfeffer M; Torp-Pedersen C; Kober L; Hall A; Pogue J; Latini R; Collins R;
    Lancet; 2002 Oct; 360(9339):1037-43. PubMed ID: 12383982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.
    Lee VC; Rhew DC; Dylan M; Badamgarav E; Braunstein GD; Weingarten SR
    Ann Intern Med; 2004 Nov; 141(9):693-704. PubMed ID: 15520426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
    Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Schiele R; Gitt AK; Juenger C; Heer T; Meisenzahl C; Landgraf H; Bossaller C; Senges J;
    Am J Cardiol; 2002 Nov; 90(10):1045-9. PubMed ID: 12423701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
    Tran CT; Laupacis A; Mamdani MM; Tu JV
    Am Heart J; 2004 Nov; 148(5):834-41. PubMed ID: 15523314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction.
    Hurlen M; Hole T; Seljeflot I; Arnesen H
    Eur J Heart Fail; 2001 Mar; 3(2):203-7. PubMed ID: 11246058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.